Related Experiment Videos
The presence of CD28-negative T cells in a patient with multicentric Castleman's disease
T Ishiyama1, M Koike, T Kakimoto
1Department of Hematology, Showa University School of Medicine, Tokyo, Japan.
Annals of Hematology
|October 1, 1996
Abstract:
We found increased numbers of CD28-negative T cells in a patient with multicentric Castleman's disease (MCD), who also had significantly decreased interleukin-2 (IL-2) production and impaired T-cell proliferation. The presence of CD28-negative T cells may be indicative of a functional T-cell defect in MCD.
Insights
Multicentric Castleman's disease (MCD) is associated with increased CD28-negative T cells, indicating a potential T-cell defect. This finding may explain reduced interleukin-2 (IL-2) production and impaired T-cell proliferation in MCD patients.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder.
- T-cell dysfunction is implicated in various immune-related conditions.
Observation:
- A patient with multicentric Castleman's disease (MCD) presented with elevated levels of CD28-negative T cells.
- This patient also exhibited diminished interleukin-2 (IL-2) production.
- Impaired T-cell proliferation was noted in the patient.
Findings:
- The study identified a correlation between increased CD28-negative T cells and functional T-cell defects in MCD.
- CD28-negative T cells may play a role in the pathogenesis of MCD.
Implications:
- The presence of CD28-negative T cells could serve as a biomarker for T-cell dysfunction in MCD.
- Understanding this T-cell defect may lead to novel therapeutic strategies for MCD.